We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.00 | 1.95 | 2.05 | 2.00 | 2.00 | 2.00 | 108,096 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.38 | 15.51M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2020 11:01 | Perhaps they had a bid (although they should release that) but Carl wanted to hang on, or vice versa. I assume he retains his holding? | deeppockets | |
30/4/2020 10:57 | At this rate might be heading for 100% rise today | 78steve | |
30/4/2020 10:56 | Something has got to be around the corner. Big US deal Big company eyeing Shield up now Carl has released his “baby” ? | peachie 74 | |
30/4/2020 10:54 | Perhaps chinese will come in knock out bid 275p. | montyhedge | |
30/4/2020 10:53 | 6 months ago I was topping up at this Level thinking I was definitely at the bottom ! Still away to go to levels we should be at imho. £2 min before news. | peachie 74 | |
30/4/2020 10:46 | Amazing rise today. Surely there must be something behind it. Bizarrely in the early hours this morning, I was thinking about why Carl Sterrit left so precipitately. Yes I know, I am sad! But to carry on my thought process, the dramatic rise since the initial plunge after the news came out, suggests to me some corporate shenanigans going on behind the scene. I think there was a fundamental disagreement about strategy and my bet is that they are now looking for a buyer of the whole company. Pure speculation but the conclusion I came to at 4 this morning! | nobbygnome | |
30/4/2020 10:28 | Something its seems about to happen, always someone knows more than us, shareprices talk and this shouting news shortly. | montyhedge | |
30/4/2020 10:25 | Bubbling up nicely - 119.90/128.10 (IG) Makes me wonder if CS was being obstinate ... | daveboy1 | |
30/4/2020 10:24 | Wonder why it's rising. Has there been a leak? | 78steve | |
30/4/2020 10:24 | We’re on board peachie lol for ages, certainly some usual activity, a few select investors must be hearing some pleasing news me thinks | ny boy | |
30/4/2020 09:27 | Yep patience. If you’re holding ! This is running away atm if your not on board | peachie 74 | |
30/4/2020 09:08 | Onwards and upwards, stay safe - stay patient | ny boy | |
30/4/2020 09:06 | Steve. The RNS did not make this go to 50. It was an accumulation of Covid scare Griffiths sold millions at a time of no real volume. Only way he could sell was taking the price so far down. He has sold fair amounts over lots of shares recently. The RNS about the H2H was an minor typo almost about inclusion data. Also it was only referencing GI patients. Shields product applies to all forms of iron deficiency. Edison maintained their 295 target after this. But DYOR mate. With ANY share you never know what’s around the corner. Otherwise we would all be millionaires ! | peachie 74 | |
30/4/2020 09:01 | Those are the people that deserve to, and do miss the bus to the party. Top Asian pharma doesn't cough up millions up front on the basis of a flaky rns ... | daveboy1 | |
30/4/2020 08:45 | I think some people's confidence has been shaken due to recent rns that made it hit 50p makes you wonder what else will come to light. How do you tell if this is undervalued or not based on what i mean it's not based on actual sales numbers | 78steve | |
30/4/2020 08:36 | What a great chart.... | nobbygnome | |
30/4/2020 08:24 | Scary how quick this rises. Relatively small number of shares in PI hands. People going to be left behind here very quickly if this continues | peachie 74 | |
30/4/2020 07:51 | Off we go again. I’ve said it before , these IMO are cheap as chips. DYOR , but we have a derisked treatment for the worlds biggest deficiency. It can compete with IV iron which requires hospitalisation etc FDA BROAD label granted ASK paying multi millions to expand us into China and Hong Kong Patents for years The rest of the world to conquer ! | peachie 74 | |
29/4/2020 18:23 | They’ve not reported that they’ve submitted for pricing in any market since the H2H was released. There was an analysis released which said it was cost effective I think. No doubt in my mind they would be and they should get pricing if Norgine pulled its fat finger out. | crankyman | |
29/4/2020 18:18 | Here you go best. To make you feel better ! | peachie 74 | |
28/4/2020 17:52 | There’s not been any prices negotiated based on that data | crankyman | |
27/4/2020 21:30 | Lako.... discussed previous Cranky. Agree totally. | peachie 74 | |
27/4/2020 20:59 | Isn't there a potential issue here with Teva? Doesn't seem to be mentioned? | lako42 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions